Differences over stem cell potentials

Are iPS cells better than embryonic stem
cells? For anyone interested in the ethical dimension of regenerative medicine,
this is a hot topic. Gretchen Vogel weighs up the latest research in the March
5 issue of the journal Science. Some recent papers suggest that induced
pluripotent stem cells – which have less ethical baggage because they do not
involve the destruction of embryos – have less medical potential than iPS
cells.

In one of these, Robert Lanza, of Advanced
Cell Technology, found that iPS cells were capable of producing far fewer cells
than human embryonic stem cells (hESCs). In one experiment, the difference was
a thousand to one. The iPS cells also aged more quickly and died sooner than
hESCs. “These cells are pretty screwed up,” Lanza commented.

However, James Thomson, of the University
of Wisconsin, the scientist who first isolated hESCs, is more optimistic. “The
differences are real, but one shouldn’t overinterpret them. When you go back
and tweak the conditions, [iPS cells] seem to have the same potential” as ES
cells, he says. The differences may be due to imperfections in the reprogramming
process that morphs a skin cell into an iPS cell. “There’s going to be a lot of
noise” in the data as scientists work to diagnose and overcome reprogramming’s
weak spots, Thomson says.

He tried to turn both hESCs and iPS cells
into neural cells and found that 90% of the hESCs made the transition. Of the
iPS cells, 79% of one line and only 15% of another line did. However, another
leading stem cell scientist, Hans Schöler, of the Max Planck Institute for
Molecular Biomedicine in Münster, Germany, says he has noticed no differences
between hESCs and iPS cells when they changed into neural stem cells. But he,
too, acknowledges that reprogramming is still an inexact science.

Shinya Yamanaka, of Kyoto University, who
was the first to successfully reprogram mature mouse cells into iPS cells, has
also observed that iPS and hESCs vary from line to line, thought not
systematically. He told Science that adding factors to the reprogramming mix
should produce more dependable iPS cells. ~ Science, Mar
5

Michael Cook
stem cells

• Author
• Recent Posts

Michael Cook

Michael Cook edits BioEdge, a bioethics newsletter, and MercatorNet, an on-line magazine whose focus is human dignity. He writes from Sydney, Australia.

Latest posts by Michael Cook (see all)

• How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
• House of Lords debates assisted suicide—again - October 28, 2021
• Spanish government tries to restrict conscientious objection - October 28, 2021